Related Experiment Videos
In utero gene therapy: current challenges and perspectives
Simon N Waddington1, M Gabriela Kramer, Ruben Hernandez-Alcoceba
1Gene Therapy Research Group, Sir Alexander Fleming Building, Imperial College, South Kensington, London SW7 2AZ, UK.
Summary
In utero gene therapy offers a promising approach for treating serious monogenetic diseases by intervening early. Advances in prenatal diagnosis, surgery, and vector design make this a feasible and potentially superior alternative to later treatments.
Area of Science:
- * Molecular Biology
- * Genetics
- * Developmental Biology
Background:
- * Significant advancements in prenatal diagnosis and surgical techniques.
- * Improvements in vector design enhance the feasibility of in utero gene therapy.
- * Adult gene therapy progress highlights potential benefits of early intervention.
Purpose of the Study:
- * To reappraise the feasibility of in utero gene therapy for severe monogenetic disorders.
- * To explore the advantages of early therapeutic intervention through prenatal gene therapy.
- * To review current and future strategies and vectors for prenatal gene therapy.
Main Methods:
- * Review of existing literature on prenatal diagnosis, surgery, and gene therapy vectors.
- * Analysis of the potential benefits of early intervention for specific monogenetic diseases.
- * Examination of strategies and vector developments for prenatal vector administration.
Main Results:
- * Progress in prenatal interventions and vector technology supports the viability of in utero gene therapy.
- * Early or prenatal treatment may overcome obstacles associated with adult gene therapy.
- * Specific monogenetic diseases are identified as strong candidates for prenatal gene therapy.
Conclusions:
- * Prenatal gene therapy is a viable and advantageous therapeutic strategy for serious monogenetic diseases.
- * Early intervention via in utero gene therapy holds significant promise for improved patient outcomes.
- * Continued development in vector design and delivery methods is crucial for advancing prenatal gene therapy.